[1] SzaboZ,HakansonE,SvedjeholmR, .Early post-operative outcome and medium-term survival in 540 diabetic and 2239 non-diabetic patients undergoing coronary artery bypass grafting,Ann Thorac Surg. -
[2] CarsonJL,ScholzPM,ChenAY, 2002.Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery,J Am Coll Cardiol 40 418 -23
[3] CarvalhoG,MooreA,QuizilbashB, 2004.Maintenance of normoglycaemia during cardiac surgery,Anesth Analg 99 319 -321
[4] WalshTS,BradburyA,ForsytheJ,ParksR, 2007.The metabolic response to surgery,Principles and Practise of Surgery. 5th edition 1 -12
[5] 2006.,Anesth Analg 103 21 -37
[6] JacobyR,NestoR, 1992.Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis,J Am Coll Cardiol 20 736 -44
[7] HanazakiK,MaedaH,OkabayashiT, 2009.Relationship between perioperativeglycaemic control and post operative infections,World J Gastroenterol 15 4122 -25
[8] LiuG,DochertyJC,RendellJCT, 2002.High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation,J Am Coll Cardiol 39 718 -25
[9] SvenssonS,SvedjeholmR,EkrothR, 1990.Trauma metabolism of the heart: uptake of substrates and effects of insulin early after cardiac operations,J Thorac Cardiovasc Surg 99 1063 -73
[10] MalmbergK,RydenL,EgendicS., 1995.Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year,J Am Coll Cardiol 26 57 -65
[11] Van den BergheG,WoutersP,WeekersF, 2001.Intensive insulin therapy in critically ill patients,N Engl J Med 345 1359 -67
[12] DeBrouwereR, 2000.Tight intraoperative glucose control improves outcome in cardiovascular surgery,J Cardiothorac Vasc Anesth 14 479 -81
[13] AbdellaN,MosimineyiO,MoussaM, 2002.Case control study of C-reactive protein with coronary heart disease in patients with type 2 diabetes mellitus,Diabetes 51 1165 -66
[14] HotamisligilGS,ArnerP,CaroJF, 1995.Increased adipose tissue expression of tumor necrosis factor in human obesity and insulin resistance,J Clin Invest 95 2409 -15
[15] GuerciB,BohmeP,Kearney-SchwartzA, .Endothelial dysfunction and type 2 diabetes,Diabetes Metab. -
[16] VermaS,MaitlandA,WeiselRD, 2002.Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism,J Thorac Cardiovasc Surg 123 1120 -24
[17] GuzikTJ,MussaS,GastaldiD., 2001.Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD (1)H oxidase and endothelial nitric oxide synthase,Circulation 105 1656 -62
[18] DaviG,CatalanI,AvernaM., 1990.Thromboxane biosynthesis and platelet function in type II diabetes mellitus,N Engl J Med 322 1769 -74
[19] MarfellaR,EspositoK,GiontaR, 2000.Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia,Circulation 101 2247 -51
[20] RaoV,MeranteF,WeiselRD, 1998.Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia,J Thorac Cardiovasc Surg 116 485 -94
[21] DandonaP,AljadaA,MohantyP, 2001.Insulin inhibits intranuclear nuclear factor kB and stimulates kB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect,J Clin Endocrinol Metab 86 3257 -65
[22] WahabNN,CowdenEA,PearceNJ, 2002.Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era,J Am Coll Cardiol 40 1748 -54
[23] NorhammarAM,RydenL,MalmbergK., 1999.Admission plasma glucose: independent risk factor for longterm prognosis after myocardial infarction even in non-diabetic patients,Diabetes Care 11 1827 -31
[24] IwakuraK,ItoH,IkoshimaM., 2003.Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction,J Am Coll Cardiol 41 1 -7
[25] FurnaryAP,GaoG,GrunkemeierGL, 2003.Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting,J Thorac Cardiovasc Surg 125 1007 -21
[26] GaoF,GaoE,YueT-L, .Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of P13-kinase, AKT, and endothelial nitric-oxide synthase phosphorylation, -
[27] Circulation, 2002., 105 1497 -1502
[28] Vanden BergheG,WoutersP,WeekersF, 2001.Intensive insulin therapy in critically ill patients,N Engl J Med 345 1359 -67
[29] LazarHL,ChipkinSR, 2004.Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischaemic events,Circulation 109 1497 -1502
[30] HoedemaekersCW,PickkersP,NeteaMG, 2005.Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial,Crit Care 9 790 -97
[31] KoskenkariJK,KaukorantaPK,KiviluomaKT, 2005.Metabolic and hemodynamic effects of high-dose insulin treatment in aortic valve and coronary surgery,Ann Thorac Surg 80 511 -17
[32] GhandiGY,NuttallGA,AbelMD, 2007.Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery,Ann Intern Med 146 233 -43
[33] IngelsC,DebaveyeY,MilantsI., 2006.Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4 years survival, dependency on medical care, and quality of life,Eur Heart J 27 2716 -24